Ausgabe 9/2001
Inhalt (7 Artikel)
Original Article
Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity
J. Li, L. Holmes, K. Franek, K. Burgin, T. Wagner, Y. Wei
Original Article
Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor
Hideo Aoki, Masaaki Mizuno, Atsushi Natsume, Takahiko Tsugawa, Kunio Tsujimura, Toshitada Takahashi, Jun Yoshida
Original Article
A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells
Ingvil Sæterdal, Marianne K. Gjertsen, Per Straten, Jon A. Eriksen, Gustav Gaudernack
Original Article
Biodistribution of 111indium-labeled macrophages infused intravenously in patients with renal carcinoma
Véronique Quillien, Annick Moisan, Thierry Lesimple, Claudine Leberre, Louis Toujas
Original Article
Soluble ICAM-1 in breast cancer: clinical significance and biological implications
Wolfgang J. Köstler, Sandra Tomek, Thomas Brodowicz, Alexandra C. Budinsky, Maria Flamm, Michael Hejna, Michael Krainer, Christoph Wiltschke, Christoph C. Zielinski
Original Article
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes
Elke S. Bergmann-Leitner, Scott I. Abrams
Original Article
Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma
Pontus Hegardt, Bengt Widegren, Li Li, Barbro Sjögren, Christian Kjellman, Inderpreet Sur, Hans Sjögren